Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sierra Oncology, Inc.SRRA · Entity 125698 | 10% owner | February 14, 2017 | February 24, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sierra Oncology, Inc.
Report date February 14, 2017 · Filed February 24, 2017
Jointly reported with Frazier Healthcare VI, L.P., FHM VI, L.P., FHM VI, L.L.C., Frazier Life Sciences VIII, L.P., FHM LIFE SCIENCES VIII, L.P., FHM LIFE SCIENCES VIII, L.L.C., Naini Nader J, Every Nathan R, Heron Patrick J
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,186,195 |
Reported balance
Holding disclosure · report date 2017-02-14 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,186,195 F1: Represents shares held by Frazier Healthcare VI, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 5,925,926 |
Reported balance
Holding disclosure · report date 2017-02-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,925,926 F2: Represents shares held by Frazier Life Sciences VIII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares held by Frazier Healthcare VI, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
F2: Represents shares held by Frazier Life Sciences VIII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ANAPTYSBIO, INC
Report date May 11, 2018 · Filed May 15, 2018
Jointly reported with Frazier Healthcare VII, L.P., Frazier Healthcare VII-A, L.P., FHM VII, L.P., FHM VII, L.L.C., Naini Nader J, Every Nathan R, Heron Patrick J
Section 16 reporting ended · disclosed 2018-05-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 973,612 |
Reported balance
After 2018-05-11 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2018-05-11 · Other · Disposed 1,372,000 · Balance 973,612 F1: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2018 Filed May 15, 2018 18:25 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | OtherCommon Stock | 1,372,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-18-000437 · edgar.xml · nonDerivative · entry 1 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 973,612 F1 · kind: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F1 · ownership.nature: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| May 11, 2018 Filed May 15, 2018 18:25 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | OtherCommon Stock | 1,372,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-18-000436 · edgar.xml · nonDerivative · entry 1 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 973,612 F1 · kind: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F1 · ownership.direct: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 17:14 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | OtherWarrants · Derivative | 117,235 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001012975-17-000092 · edgar.xml · derivative · entry 2 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 117,235 shares Expires 2018-11-04 F1 · derivative.exercise_date: This warrant is exercisable at any time. F2 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 17:14 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | OtherCommon Stock | 117,235 | $4.55 | $533,419.25 |
DisclosureSEC source: 0001012975-17-000092 · edgar.xml · nonDerivative · entry 1 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,345,612 F2 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 17:14 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | OtherWarrants · Derivative | 117,235 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001012975-17-000091 · edgar.xml · derivative · entry 2 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 117,235 shares Expires 2018-11-04 F1 · derivative.exercise_date: This warrant is exercisable at any time. F2 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 17:14 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | OtherCommon Stock | 117,235 | $4.55 | $533,419.25 |
DisclosureSEC source: 0001012975-17-000091 · edgar.xml · nonDerivative · entry 1 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,345,612 F2 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionSeries D Preferred Stock · Derivative | 209,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 12 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 209,095 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.exercise_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.expiration_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F7 · derivative.underlying_shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionSeries D Preferred Stock · Derivative | 733,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 11 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 733,740 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.exercise_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.expiration_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F6 · derivative.underlying_shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F6 · ownership.direct: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionSeries C-1 Preferred Stock · Derivative | 195,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 10 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 195,751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F3 · derivative.exercise_date: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F3 · derivative.expiration_date: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionSeries C Preferred Stock · Derivative | 604,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 9 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 604,055 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F2 · derivative.exercise_date: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F2 · derivative.expiration_date: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionSeries B Preferred Stock · Derivative | 1,428,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 8 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,428,571 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F1 · derivative.exercise_date: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F1 · derivative.expiration_date: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | PurchaseCommon Stock | 88,709 | $15.00 | $1,330,635.00 |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 7 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 88,709 F7 · shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | PurchaseCommon Stock | 311,291 | $15.00 | $4,669,365.00 |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 6 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,291 F6 · shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F6 · ownership.direct: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionCommon Stock | 209,095 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 5 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 209,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F4 · price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionCommon Stock | 733,740 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 4 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 733,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F4 · price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F6 · ownership.direct: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionCommon Stock | 195,751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 3 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 195,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F3 · price: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionCommon Stock | 604,055 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 2 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 604,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F2 · price: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionCommon Stock | 1,428,571 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 1 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,428,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F1 · price: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionSeries D Preferred Stock · Derivative | 209,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 12 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 209,095 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.exercise_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.expiration_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F7 · derivative.underlying_shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionSeries D Preferred Stock · Derivative | 733,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 11 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 733,740 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.exercise_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.expiration_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F6 · derivative.underlying_shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F6 · ownership.nature: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionSeries C-1 Preferred Stock · Derivative | 195,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 10 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 195,751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F3 · derivative.exercise_date: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F3 · derivative.expiration_date: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionSeries C Preferred Stock · Derivative | 604,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 9 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 604,055 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F2 · derivative.exercise_date: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F2 · derivative.expiration_date: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionSeries B Preferred Stock · Derivative | 1,428,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 8 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,428,571 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F1 · derivative.exercise_date: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F1 · derivative.expiration_date: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | PurchaseCommon Stock | 88,709 | $15.00 | $1,330,635.00 |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 7 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 88,709 F7 · shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | PurchaseCommon Stock | 311,291 | $15.00 | $4,669,365.00 |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 6 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 311,291 F6 · shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F6 · ownership.nature: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionCommon Stock | 209,095 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 5 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 209,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F4 · price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionCommon Stock | 733,740 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 4 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 733,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F4 · price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F6 · ownership.nature: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionCommon Stock | 195,751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 3 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F3 · price: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionCommon Stock | 604,055 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 2 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 604,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F2 · price: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC | ANAPTYSBIO, INC ANAB · Entity 4640 | ConversionCommon Stock | 1,428,571 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 1 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F1 · price: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.